Abstract. This study examined the possibility that in Alzheimer disease (AD) ␤-amyloid precursor protein (␤APP) mRNA is delivered to senile plaques (SPs) via dendritic processes. ␤APP mRNA was detected in SPs by in situ hybridization, using a 1.4-kb cRNA in which both [
INTRODUCTION
Senile plaques (SPs) and neurofibrillary tangles (NFTs) represent the most frequent lesions found in brain parenchyma of Alzheimer disease (AD) victims. SPs contain extracellular deposits of toxic ␤-amyloid peptides (A␤) that are produced by aberrant processing of ␤-amyloid precursor protein (␤APP) (1) (2) (3) (4) (5) . Processes causing SP formation away from neuronal cell bodies have not been identified.
SPs are structurally complex lesions, the temporal development of which is only partially understood. It is believed that SPs represent amorphous deposits of 39-43 amino acid hydrophobic self-aggregating A␤ peptides (1) (2) (3) (4) (5) . SPs stain with several fluorescent dyes, including thioflavin S (ThS) (6) , reduce monovalent silver (7) , and bind A␤-specific antibodies (8) (9) (10) (11) (12) . According to their maturation, SPs are classified as immature or primitive and diffuse plaques, and mature dense-cored and burnedout (compact) plaques (13) (14) (15) . Using end-specific A␤ monoclonal antibodies, Iwatsubo et al (8) showed that mature, dense-cored, and compact plaques consist of A␤ , (or a mix of A␤ and A␤ 1-42/43 ), and that immature, diffuse plaques immunostain mostly for A␤ 1-42/43 . Immature SPs contain also both N-and C-termini of ␤APP (16) (17) (18) (19) . A subset of SPs immunostains with amyloid precursor-like protein (APLP1, APLP2, and ␤APP) antibodies (20) , suggesting that, in addition, these precursors are present within plaques.
The present research considers that ␤APP synthesis may occur in immature SPs, starting at the mRNA level. This view is supported by Ginsberg et al (21) indicating the presence of multiple mRNA species in extracts from individual SP. So far, no ␤APP mRNA has been shown in immature SPs. Occasionally, ␤APP mRNA has been noted in mature SP hybridization with digoxigenin-labeled riboprobes (21, 22) . However, in view of the pitfalls of digoxigenin-based in situ hybridization (ISH) in brain tissue (23) , doubts persist about the specificity of ␤APP mRNA labeling within mature SPs. Instead, in this study, mRNA was detected by ISH using both radiolabeled and biotin-labeled cRNAs. To compare mRNA levels in immature and mature SPs, the cerebral cortex of human presenile AD cases and AD cases was analyzed. The presenile AD brain displays mostly immature, diffuse SPs, whereas the senile AD brain generally contains dense-cored and compact SPs (24) . ␤APP mRNA was compared with that of furin, a proteolytic enzyme putatively involved in ␤APP processing, and with its orthologue, proprotein convertase (PC1), as a control (25) . As plaque pathogenesis is a sequential process with an evolutional relationship between ␤-amyloidosis and NFT (26) , co-localization of the plaque maturation markers A␤ and A␤ was compared with neurofilament protein 200 (NF200), as a marker of dystrophic neuronal processes (27) (28) (29) . Finally, to confirm the presence of dystrophic dendrites in SPs, an immunostaining technique with a dendrite marker, microtubule-associated protein 2 (MAP2) (30) , was developed. The results of this analysis suggest that immature SPs containing A␤ and dystrophic dendrites, and to a much lesser extent mature Human temporal cortex tissues used in the present study were obtained from the Brain Bank of the Douglas Hospital Research Centre, Verdun, Quebec, Canada. Autopsy was performed within a postmortem period of 16 hours (h). A total of 15 cases involving both sexes were studied as described previously (24) : 7 control subjects (58-88-yr-old), 5 clinically diagnosed senile AD cases (76-95-yr-old), and 2 presenile AD cases with clinically identified early disease onset (57-and 66-yr-old, respectively). A third presenile AD case (57-yr-old) had been identified, but the results were not considered for quantification because of a postmortem delay extending to 36 h, causing a low hybridization signal. The classification of AD was based on clinical and neuropathological criteria provided by the Brain Bank and on the occurrence of mature amyloid SPs. Considered as presenile were cases which, in addition to clinical and neuropathological criteria, displayed a significant number of preamyloid primitive plaques, and immature, diffuse amyloid plaques (24) . The Ethics Committee of the Clinical Research Institute of Montreal approved this research protocol.
For ISH and Western blotting, brain tissues were kept frozen at Ϫ80ЊC in hermetically-sealed vials until used, thawed to Ϫ28ЊC, and cut into 8-m sections with a cryostat. The sections were fixed for 1 h with 4% formaldehyde in 0.1 M phosphate buffer, pH 7.4. In addition to cryostat sections, brain tissues were also embedded in paraffin and cut into 5-m sections.
In Situ Hybridization
For ISH, radiolabeled riboprobes for human ␤APP (cDNA equivalent 795-2,208, Gene Bank accession number AB015751) (24) (24) , resulting in a specific activity of 1,017; 1,792 and 1,957 Ci/mmol, respectively. For autoradiography, the sections were dipped in photographic emulsion (NTB-2, Kodak), exposed for 6 (␤APP), 14 (furin) and 21 (PC1) days at 4ЊC before development in D19 solution (Kodak) and staining with hematoxylin. To decrypt SPs, after ISH the sections were treated for 1 h with 1% aqueous ThS solution (6, 31) , dehydrated with 70% ethanol, and cleared with glycerol. They were then examined under UV illumination. ThS staining revealed a presence of SPs of different types. According to their morphology, they were classified as primitive or immature plaques (70-90-m-diameter, softly delineated from the adjacent neuropil plaques containing weakly stained, evenly distributed fibrils); diffuse plaques (ϳ50 m-diameter, sharply delineated plaques containing a moderately stained, abundant, evenly distributed amyloid deposits); dense-cored plaques (ϳ50 mdiameter, sharply delineated plaques with an amyloid core in the center surrounded by a corona containing diffuse amyloid deposits separated from the core by a small gap) and compact plaques (ϳ30 m-diameter, strongly stained, sharply delineated from the neuropil pure core without associated diffuse amyloid deposits). Image analysis of ISH was done on emulsion-dipped slides by counting silver grains/m 2 in cell bodies and plaques, using Northern Eclipse software set at 0.2-m-diameter as the maximal limit of silver grain detection. Specific hybridization values of silver grains/m 2 were calculated as total values minus background values measured in slides hybridized with sense riboprobes. Statistics were analyzed by Student t-test.
Biotin-labeled ␤APP riboprobes were manufactured with Biotin-16-UTP (catalogue number 1 388 908, Boehringer Mannheim Biochemica, Mannheim, Germany), and the ISH procedure was performed as described earlier (24) . Biotin-labeled hybrids were detected according to the streptavidin-horseradish peroxidase-tyramide method, using a catalyzed signal amplification system for ISH (catalogue number KO620, Dako Corporation, Carpinteria, CA). The hybridization signal was seen as a brown-red precipitate.
Immunocytochemical Localization of A␤ Peptides
SPs were detected on cryostat sections by immunocytochemistry (ICC) with 4 monospecific antibodies recognizing different antigenic sites within the A␤ sequence: rabbit anti-A␤ [1] [2] [3] [4] [5] [6] [7] [8] NF200 was detected by mouse monoclonal antibodies (catalogue number NCL-NF200, Novocastra). Western blotting was performed as described for other proteins (33) . Briefly, control and diseased cortical regions were extracted in extraction buffer (Tris-HCl 50 mM, pH 7.4, EDTA 2.5 mM, and NaCl 150 mM) containing freshly dissolved protease inhibitors (leupeptin 2 g/ ml, aprotinin 2 g/ml, pepstatin 100 M, A-PMSF 100 g/ml) and ␤-mercaptoethanol 2 mM. Approximately 50 g of protein was subjected to 8% Tris-Tricine sodium dodecyl sulphatepolyacrylamide gel electrophoresis, then transferred onto PVDF protein transfer membranes and incubated with a primary antibody to NF200 dissolved 1:500, or mouse anti-␤-actin (Sigma) dissolved 1:500. For visualization, the immunoreaction blots were incubated with anti-mouse IgGs (Sigma) diluted 1:5,000, and the product of peroxidase activity was revealed with the BM Chemiluminescence blotting substrate POD (Boehringer Mannheim, Germany). cases. The same sections stained by thioflavin S are also shown (ThS column). ISH was carried out as described in Materials and Methods using radiolabeled antisense riboprobes (as) and control sense riboprobes (ss). Neuronal localization of ␤APP mRNA is indicated by small arrows, diffuse plaques by medium arrows, and cored plaques by large arrows. Magnification: ϫ210; scale bar ϭ 100 m.
ICC staining was performed on paraffin sections. Anti-NF200 diluted 1:200 was incubated overnight at 4ЊC and was revealed with secondary anti-mouse IgG conjugated to alkaline phosphatase (catalogue number A4312, Sigma Chemical Co.) and with alkaline phosphatase substrate kit (catalogue number SK-5300, Vector Laboratories Inc.) as described elsewhere (34) . This immunostaining generated blue precipitate. Sequential immunostaining with anti-A␤ or anti-A␤ , both in 1:1,000 dilution was revealed following overnight incubation at 4ЊC. Rabbit antibodies were detected with the biotin-streptavidin method coupled with horseradish peroxidase (Histostain Plus kit, catalogue number 85-9843, Zymed Laboratories, Inc.) producing brown labeling.
Immunocytochemical Localization of Microtubule-Associated Protein 2 (MAP 2)
MAP2 was detected by mouse monoclonal antibodies (Clone AP30, catalogue number MS249, NeoMarkers Inc., Fremont, CA). According to the manufacturer, MAP2 detection requires the epitope retrieval procedure without aldehyde fixation. Two distinct epitope retrieval techniques were developed. First, to give preference to MAP2 staining in cell bodies and dendrites, the antigen was recovered by treatment of unfixed frozen brain sections by immersion in pure acetone for 10 min at room temperature, followed by boiling in 10 mM sodium citrate buffer, pH 6.0, for 20 min, as recommended by the manufacturer (NeoMarkers Inc.). In the second procedure, to reveal MAP2 staining in dystrophic dendrites, cryostat sections were immersed in 95% ethanol for 20 min at 4ЊC. After this treatment, exposure to a blocking agent (Catalogue # 95-9999 Histostain DS Double Staining, Zymed Laboratories Inc.) for 10 min neutralized nonspecific sites. Anti-MAP2 diluted 1:25 in blocking agent was applied on sections for 48 to 72 h incubation at 4ЊC, then washed in phosphate-buffered saline and incubated with a biotin-labeled second antibody, streptavidin-horseradish peroxidase HRP and revealed as a brown-red precipitate according to the manufacturer's procedure (Zymed Laboratories, Inc.). Controls performed by omission of the first antibody were negative, emphasizing the specificity of the MAP2 immunoreaction. Figure 1 shows the ␤APP mRNA hybridization signal (10-to 20-m) found within neuronal cells (small arrows). In addition to cellular localization, in presenile AD and senile AD cases the presence of ␤APP mRNA transcripts was evident within plaques whose diameter ranged from 50 to 80 m (Fig. 1D, E be identified under light-field (LF) on plaque ISH labeling. However, glial and neuronal cells were often seen in the vicinity or in the border of larger plaques. Labeled plaques were observed in regions containing neuritic plaques revealed by preliminary Bielschowsky's silver impregnation staining. Control hybridization with sense cRNA probes was negative, producing uniform background labeling throughout the cell bodies and SPs, emphasizing the specificity of ISH (Fig. 1J, K) .
RESULTS mRNA Concentration in SPs
␤APP mRNA hybridization levels in SPs showed much higher intensity in presenile AD than in senile AD cases (Fig. 1D, E versus G, H) . The presenile AD brain cortex displayed mostly immature SPs. These were identified by ThS staining on the same sections (Fig. 1F, I , medium arrows) revealing the prevalence of primitive and diffuse SPs with fewer dense-cored SPs. Most of the diffuse SPs displayed ␤APP mRNA labeling spread throughout their entire structures (Fig. 1D, I , medium arrows). Dense-cored SPs were also labeled, but weakly, showing ␤APP mRNA present within the corona but not in the plaque center (Fig. 1G-I , large arrows). In senile AD cases, mature, dense-cored and compact SPs predominated over immature, diffuse SPs. Despite their scarcity, mostly diffuse SPs contained ␤APP mRNA (Fig. 1G-I , medium arrows).
Semiquantitative comparison between ␤APP mRNA concentration in diffuse and compact SPs in presenile AD and senile AD cases is illustrated in the Table. The Table  shows the density of silver grains in plaques versus cell bodies and a calculated index of mRNA concentration (IMRC). Note that IMRC values remain relatively constant between presenile and senile AD cases and a 2-number IMRC value for diffuse SPs drops to a 1-number IMRC value for compact SPs. These findings suggest that ␤APP mRNA segregation and concentration occur mostly within diffuse SPs, and less so in dense-cored and compact SPs. Consequently, mRNA-positive SPs might represent formations containing subcellular compartments, in contrast to mRNA-negative, dense-cored and compact SPs that are likely amorphous structures.
␤APP mRNA and A␤ Peptides in Primitive Plaques
To corroborate ThS staining, ␤APP mRNA labeling was compared with A␤ immunostaining. To this end, 4 different monospecific antibodies were used, including rabbit antibodies recognizing a free N-terminus of A␤ (anti-A␤ 1-8 ) (32), a middle portion A␤ (anti-A␤ [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] ), and C-terminally-directed anti-A␤ 1-40 and A␤ (see Materials and Methods). An example of a primitive plaque labeled both by ISH ( Fig. 2A, large arrow) and ICC using anti-A␤ [1] [2] [3] [4] [5] [6] [7] [8] (Fig. 2B) is demonstrated in cortical layer I of a presenile AD case. It is apparent that ␤APP mRNA ( Fig. 2A ) and the N-terminal extension of A␤ peptide (Fig. 2B ) co-localize within plaques. A positive immunoreaction was also obtained using C-terminally A␤ 1-42 -directed antibodies. As indicated schematically in Figure 2C , much less, if any, immunoreactivity was evident with anti-A␤ [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] and anti-A␤ . Considering this bipolar distribution of immunoreaction which deserted a middle portion of the A␤ sequence spanning the ␣-processing site (HHQK 16 ↓LV) and a C-terminal sequence of A␤ , and according to the mass spectrum analysis data published by other authors (35) , it can be postulated that the N-terminal fragment, presumptively A␤ [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] (p2), is separated from the C-terminal fragment(s), presumptively A␤ The index of mRNA concentration (IMRC) was based on specific silver grain density (total labeling minus background determined by sense riboprobes) per 100 m 2 area Ϯ SD in both ThS-stained SPs and neuronal cell bodies from 2 presenile and 2 AD cases, n ϭ 20 for each individual. Abbreviations: IMRC ϭ index of mRNA concentration; AD ϭ Alzheimer disease case; PreS ϭ presenile case; C ϭ dense-cored SP; D ϭ diffuse SP; nd ϭ not determined.
*p Ͻ 0.001.
or both, in primitive plaques. This also suggests that ␣-secretase activity (Fig. 2C, arrow) is still present within primitive plaques. In contrast to primitive plaques, diffuse, dense-cored and compact SPs were immunostained by the anti-A␤ [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] antibody recognizing the middle A␤ portion (data not shown). This might indicate that they contain little, if any, ␣-secretase activity. As seen in Figure 2B for anti-A␤ [1] [2] [3] [4] [5] [6] [7] [8] and indicated schematically in Figure 2D for the remaining anti-A␤ [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , anti-A␤ , and anti-A␤ , all 4 antibodies immunostained the amyloid deposits present around blood vessels. In agreement with the observation published by Vidal et al (36) , anti-A␤ 1-40 immunostained vascular amyloid deposits more intensely than anti-A␤ .
␤APP mRNA in SPs after Biotin Labeling
Alternative ISH with biotin-labeled cRNA was used to confirm the presence of ␤APP mRNA in SPs. This procedure, although less sensitive than the ISH variant with radiolabeled cRNA probes, generated red-brown labeling within cells and their extensions. In many control, presenile AD, and senile AD neurons, the dendritic proximal compartments were decorated with red-brown ␤APP hybridization staining (Fig. 3A, arrows) . Well-preserved, labeled, diffuse SPs (50-to 70-m-diameter) were frequently observed in presenile AD (Fig. 3B) , and sporadically in control brains (data not shown). These SPs displayed clearly delineated borders, suggesting that ␤APP mRNA is confined to closed compartments of primitive plaques. In contrast to presenile AD where SPs were labeled, biotin labeling was much less pronounced in diffuse SPs in senile AD and undetectable in densecored and compact (burned-out) SPs (data not shown).
Furin and PC1 mRNA in SPs
Because of their possible involvement in ␤APP biosynthesis and processing (37) (38) (39) , the expression of proprotein, the convertase furin, and its orthologue PC1 was also investigated. The results obtained in presenile AD Immunocytochemical staining of NF200 and NF200/160. Immunolabeled axons are seen in the healthy cortex (A, arrow) after hematoxylin and eosin staining. In AD, a perinuclear immunoreaction is present in a neuronal cell body (B, large arrow), proximal dendrite (B, medium arrows), and in senile plaque (C, medium arrows). Note the presence of NF200/ 160 in a swollen dendrite (C, large horizontal arrow). Magnifications: A, C, ϫ400; B, ϫ800. Scale bars: A, C ϭ 50 m; B ϭ 25 m.
and senile AD provided evidence for furin mRNA concentration, mostly in diffuse SPs (Fig. 4D-I , medium arrows). Dense-cored SPs showed much less labeling (Fig.  4G-I , large arrows). PC1 mRNA was detectable in neuronal cells, but not in SPs (data not shown).
To compare the concentration of ␤APP, furin, and PC1 mRNA in SPs, silver grain density in plaques and cell bodies as well as IMRC were obtained for each mRNA species (Table) . The data indicate that comparable ␤APP and furin mRNA levels were found within SPs, whereas PC1 labeling was at the background level. In contrast, the values calculated for cell bodies were quite different, higher for ␤APP and lower for furin and PC1, giving an IMRC value of ϳ50 for ␤APP, ϳ500 for furin, and 1 for PC1. Thus, an ϳ10-fold IMRC difference between ␤APP and furin is evident, emphasizing that each IMRC has an mRNA-specific value probably due to the individual capacity of neurons to export each mRNA species into plaques. Similar to ␤APP, furin IMRC values showed a significant difference between diffuse and dense-cored SPs, being ϳ4-fold higher in the former than in the latter (Table) .
Plaque Construction and Deconstruction

NF200/160 Isoforms in Presenile AD and Senile AD Brain:
The following study was designed to identify the cellular elements that may lead to mRNA sequestration in SPs. To detect neuronal processes, NF200 (28) was chosen as a robust marker. Based on preliminary immunostaining, it shared a similar pattern of distribution with dystrophic neurites stained by Bielschowsky's silver impregnation method. As revealed by Western blotting, a hyperphosphorylated NF200 isoform migrating as a 200-kDa protein (27, 29) occurred in the cortical tissue of healthy subjects (Fig. 5 , Ctr #1 and 2). In contrast, 2 isoforms, indicated here as NF200/160 (hyperphosphorylated 200 kDa and hypophosphorylated 160 kDa), were present in presenile AD (#3) and senile AD (#4) (Fig. 5) . By ICC, NF200 was confined to axonal processes in the control brain temporal lobe cortex (Fig. 6A) . In both presenile AD and AD cases, various NF200/160 levels were also evident within proximal dendrites (Fig. 6B) and SPs (Fig. 6C) .
Comparative Distribution of A␤ , A␤ , and NF200/ 160: To demonstrate changes in dendritic network density in immature versus mature SPs, NF200/160 immunostaining was compared to that of A␤ and A␤ . As demonstrated by Iwatsubo et al (8) , A␤ 1-42 localizes preferentially to immature diffuse plaques, and A␤ 1-40 to mature, dense-cored plaques. Co-localization of NF200/160 and A␤ peptides was realized by double ICC, using alkaline phosphatase substrates staining blue, and horseradish peroxidase staining brown (see Materials and Methods). The results of double ICC revealed a different contribution of neuronal processes to immature, diffuse, and mature, dense-cored plaques. The density of the NF200/160-labeled structures (Fig. 7A-D, arrows) was higher in immature, diffuse plaques (Fig. 7A, B) than in dense-cored plaques (Fig. 7C, D) . In immature, diffuse SPs, NF200/160 co-localized with A␤ (Fig. 7B, SP42 ). In dense-cored SPs containing A␤ , a dramatic loss of density of NF200/160-labeled dystrophic fibers was evident (Fig. 7C, SP40 ). Dense-cored A␤ 1-40 immunostained SPs did not stain for A␤ . To highlight this observation, 2 adjacent paraffin sections presenting the same densecored SP40 plaque are shown after anti-A␤ 1-40 -positive immunostaining (Fig. 7C ) and anti-A␤ 1-42 -negative immunostaining (Fig. 7D) . One interpretation for this finding is that at the onset of plaque pathogenesis, NF200/ 160-labeled fibers contribute to the construction of SP42, which represent immature, diffuse SPs. In contrast, at senile AD stages, when the number of mature SPs predominates over their immature counterparts, NF200/160 immunoreaction declines significantly in dense-cored and burned-out SPs, suggesting deconstruction of the dystrophic fiber network.
Evidence for the Presence of MAP2 in Dystrophic Dendrites
To identify dendrites in SPs, MAP2 immunocytochemical staining was developed. As MAP2 immunostaining does not support aldehyde fixation, unfixed cryostat sections were used. For antigen retrieval they were alternatively treated with acetone (Ac) or ethanol (Et), as described in Materials and Methods. Following Ac treatment, the presence of immunoreactive MAP2 was detected in neuronal somata and dendrites. Figure 8A illustrates an example of immunostaining in a presenile AD brain cortex. Similar staining of neurons has also been obtained in control and AD cases after Ac treatment (data not shown). After Et treatment, numerous MAP2-containing SPs were revealed in presenile AD. The example of MAP2 plaques is shown at low (Fig. 8B ) and high magnification (Fig. 8C) . The immunolabeled structures present in SPs include fine dendrites with some swollen and fibrillar dystrophic dendrites (Fig. 8C) . In contrast to presenile AD (Fig. 8C) , both the density of MAP2-positive SPs in the cerebral cortex and the intensity of their immunostaining per individual SP are lower in AD (Fig. 8D) .
DISCUSSION
This work provides the first reliable evidence for the presence of ␤APP mRNA within immature primitive and diffuse SPs. In contrast, mature, dense-cored and burnedout SPs displayed little if any mRNA. A degree of plaque maturity can be defined based on histochemical, biochemical, and neuropathological criteria taken together. There is no ambiguity concerning some stages. Thus, classic dense-cored and compact plaques can be considered as mature based on their morphology and the occurrence of A␤ . This molecule represents a harmful form of amyloid, since it possesses domain associated with activation and recruitment of glia to SP (2) . The primitive plaque can be considered as immature because of a low ␤-amyloid concentration due to the predominance of p2 and p3 peptides over A␤ and A␤ 1-40 peptides. Here, the p3 molecule may represent a benign form of amyloid, since it lacks domains associated with glia recruitment. However, there is less clear delineation on mature and immature stages within a diffuse plaque stage that could be an intermediate stage. Diffuse plaque contains amyloid deposits, which are, most likely, a mixture of various proportions of presumptive p2, p3, and A␤ with little if any A␤ . In this work, for simplifying, it is proposed to consider a diffuse plaque more similar to an immature plaque than to a mature plaque. These findings were obtained by sensitive ISH, using highly radioactive riboprobes synthesized in vitro by double incorporation of [ 35 S]-CTP and [ 35 S]-UTP (see Materials and Methods). The presence of mRNA throughout immature SPs or within the corona of some dense-cored SPs was ascertained by ThS fluorescence. Confirmatory findings were also obtained with biotinylated riboprobes, which labeled primitive SPs. In addition to ␤APP, evidence of mRNA for furin but not PC1 in SPs was also documented, emphasizing the specificity of mRNA sequestration in SPs. Furthermore, the index of mRNA concentration (IMRC) was calculated for each specific mRNA (Table) . This observation suggests that strong forces drive furin (IMRC ϳ500) and ␤APP (IMRC ϳ50), but not PC1 (IMRC ϳ1) mRNA into immature SPs. In contrast, low IMRC values determined for ␤APP and furin in densecored SPs confirm that mRNA concentration declines in most mature SPs. However, because of a high physical density of the core where A␤ aggregates into a dense ␤-plated sheet, the possibility that cRNA probes poorly penetrate locally into 10-m cryostat sections should not be ruled out. With this limitation in mind, it is important to consider supplementary parameters to determine the degree of plaque maturity. For this purpose, ICC markers of plaque maturity, A␤ , A␤ , and a dystrophic fiber marker, NF200/160, were better because of antibodies binding to the surface of sections without the need to penetrate into the SP core. Immature, primitive, and diffuse SPs immunostained with anti-A␤ 1-42 appear to be formed around the network of NF200/160 dystrophic fibers. Dense-cored and compact SPs immunostained with anti-A␤ 1-40 contained much less dystrophic processes. Concerning the identity of dystrophic fibers, 2 findings point toward their dendritic origin. First, proximal dendrites contained an excess of NF200/160 (Fig. 6B) , suggesting that this protein is displaced into the dendritic compartment, whereas in healthy cases it is targeted to the axons. The second finding is the presence in SPs of MAP2, which is a marker of dendrites in adult neurons (30) . Immunoreactivity to MAP2 can be visualized in SPs after the retrieval of its antigenic sites by Et fixation. Unfortunately, because of the incompatibility of the fixation procedures (formaldehyde for NF200 versus Et treatment for MAP2, see Materials and Methods), it was impossible to co-localize NF200/160 and MAP2. Nonetheless, in view of their similar morphology emphasized by the presence of swollen and fibrillar processes, it is probable that NF200/160 and MAP2 cohabit the same dystrophic structures in SPs. It is, thus, likely that mRNA enters SPs via the dendritic compartment. This is also consistent with the finding by Wang et al (40) who described the intradendritic accumulation of A␤ in Purkinje cells of the cerebellum. The capacity of plaques to concentrate mRNA may correlate with the density of dystrophic dendrites, being high in immature SPs and decreasing along deconstruction of the dystrophic dendrite network to a low level in mature SPs. As far as axons are concerned, to what degree they contribute to construction SPs remains uncertain. It should not be forgotten, however, that under some circumstances (e.g. trauma), axons in adult mammalian neurons could transport mRNAs and synthesize proteins (41) .
Targeting of mRNAs to Dendritic Microdomain
The mechanism by which mRNA penetrates into and concentrates within SPs has not yet been clarified. However, the dendritic compartment could be involved in this process: ␤APP mRNA has been detected in proximal dendrites (Fig. 3A) and cell processes of dissociated hippocampal neurons (42) . The suggestion that gene transcripts are targeted for subsynaptic locations was based on the discovery that the machinery for protein synthesis, including polyribosomes and associated membranous cisterns, is selectively localized beneath postsynaptic sites on the dendrites of central nervous system neurons (43, 44) . Various components of the protein synthetic machinery have been analyzed in dendrites, including ribosomes and representatives of tRNAs, aminoacyl-tRNA synthetases, initiation and elongation factors, as well as components of the co-translational protein-sorting machinery (45) , and markers of the translational machinery and organelles of the secretory pathway, BiP for the endoplasmic reticulum, and rab1, CTR433 and TGN38 for the intermediate compartment and Golgi (Go) complex (46) . Activities of the protein glycosylation machinery (rough endoplasmic reticulum [RER]-and Go-associated glycosyltransferase activities) have been visualized in dendrites by precursor (mannose for RER, or galactose and fucose for Go) labeling methods (47) . Several species of mRNA have been localized within the somatodendritic compartment (e.g. MAP2, calmodulin kinase II, Arc, F1/ GAP43, RC3 and InsP3 receptor mRNAs in neuronal cells [44, 48, 49] ), and protein tau mRNA in the somatodendritic compartment of normal and AD brains (31) . Whether the above macromolecules, organelles, and activities can concentrate within SPs seems likely. So far, Ginsberg et al (21) have molecularly identified about 50 various RNA species sequestered within a single SP, including ␤APP and tau mRNAs. Furthermore, the presence of RER has been observed by electron microscopy within neuritic plaques developed in transgenic mice, suggesting that it participates in ␤-amyloid synthesis (50) .
Transformation of Neuronal Processes into Amyloid-Producing Microdomains
Although the cause of SP onset remains unclear, the available data indicate that mRNA sequestration in SP and ␤APP neuronal overexpression are linked. Thus, increased ␤APP gene dosage and accelerated AD-onset are associated in Down syndrome (51); a greater expression level of human ␤APP in transgenic mice induces plaque formation (50); neuronal ␤APP expression increases specifically in brain regions where widespread injury occurs (52) ; and an approximately 2-fold increase of ␤APP mRNA levels is evident in presenile AD cases in areas containing a large population of immature SPs (24) . Overproduction of the hypophosphorylated NF160 isoform over the NF200 isoform could be one of the evident characteristics of the presenile AD brain. Increased NF160 synthesis may be important for the conversion of healthy dendrites into dystrophic dendrites in AD, as proposed by Knowles et al (53) . In this sense, NF160 represents an excellent neurochemical and neuropathological marker, signaling the onset of early senile changes in the brain. Defining the stimuli that provide sufficient, permanent, and synchronized input to induce ␤APP overexpression, increased NF160 synthesis and, subsequently, a massive plaque construction step is therefore a critical question. Once formed, primitive plaque differentiates into a series of diffuse, dense-cored and burned-out SPs (Fig. 9 ) that differ from each other by concentration of specific mRNAs, predominance of specific A␤ peptides, and the contribution of a network of dystrophic dendrites. To avoid a semantic problem associated with the notion of ''differentiation'' in general, the terms ''plaque construction'' and ''plaque deconstruction'' are proposed instead. As shown in the Table, there is a significantly higher mRNA concentration in diffuse SPs (␤APP IMRC ϭ 55; furin IMRC ϭ 546) when compared to dense-cored SPs (␤APP IMRC ϭ 9; furin IMRC ϭ 140). Remodeling of shape, changes in ␤APP-derived peptide composition (replacement of p2 and p3 first by A␤ and finally by A␤ , and withdrawal of NF200/160-labeled dystrophic dendrites occur with SP deconstruction.
Onset of Aberrant ␤APP Processing in AD
Why amyloidogenic ␤APP processing takes over physiological non-amyloidogenic processing is not yet understood. Some authors postulate that post-translational events contribute mostly to SP formation (54) . It is possible that the phenomenon of differential mRNA concentration in SPs influences the changes in ␤APP processing. This would suggest that pre-translational events, such as mRNA dendritic transport and segregation into SPs, are important as well. Proteolytic enzymes involved in ␤APP processing might be differentially segregated into SPs by similar mechanisms.
Several enzymes with ␣-and ␤-secretase activities have recently been reported. The physiological processing that involves ␣-secretase activity takes place at the ␣-site (HHQK 667 ↓LV) of ␤APP 1-751 (55) . Alpha-secretasetype processing of ␤APP by membrane-bound disintegrin zinc-binding metalloproteinases belonging to the adamalysin family has been reported in cell lines. Biochemically identified candidate ␣-secretases are ADAM9 (56, 57) , ADAM10 (58) , and ADAM17 (59) . As deduced from the site-specific distribution of various A␤ antigenic sites (Fig. 2C) , ␣-secretase activity might still be present within primitive plaques, since the presumptive fragments p2 (A␤ [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] ) and p3 (A␤ 17-42/43 ) (35, 60) occur in this stage. However, the identity of ␣-secretase(s) in immature plaques remains to be established.
Aberrant ␤APP processing involves both ␤-and ␥-secretase activities at ␤-(QVKM 651 ↓DA) and ␥-(VVIA 694 ↓T↓V) sites (61) . For both, a human aspartyl proteinase BACE (also called Asp2 or memapsin2) with ␤-secretase activity has been reported (62) (63) (64) (65) (66) . Comparative distribution, colocalization, and ontogeny studies indicate that BACE mRNA is present in control and diseased brain neurons and that its levels are coordinately regulated with those of ␤APP mRNA (24) . Future studies should address the question of BACE mRNA concentrating within plaques.
This work also provides evidence for sequestration of furin mRNA within SPs. Furin belongs to a family of subtilisin/kexin-like precursor processing enzymes (25) , activating a presumptive ␣-secretase pro-ADAM10 (39) and ␤-secretase pro-BACE (37, 38) by cleaving the prosegment at the typical furin-like site composed of pairs of basic residues. The presence of furin in SPs might be critical for the differential regulation of ␣-and ␤-secretase activities. Finally, the outstanding property of furin is emphasized by a high concentration of its mRNA within SPs compared to cell bodies (Table) . Via this property, furin mRNA and/or protein appear potentially to be an excellent marker of immature plaques.
In conclusion, this research provides ISH evidence for the concentration of ␤APP and furin mRNA, mostly in immature SPs and less so in mature SPs. In reference to the changes in density of the dystrophic dendrite network along plaque maturation, compelling histochemical data have been obtained to consider that SPs undergo construction and deconstruction processes.
On the significance of the data described here, there is still ample scope for research, especially concerning the role of mRNA pre-translational events in the onset of AD. This includes mRNA cellular segregation, dendritic transport, and plaque sequestration mechanisms. Special interest should be paid to understanding the role of molecular and cellular mechanisms of mRNA export from cell bodies to plaques in discriminating between nonamyloidogenic ␣-secretase and amyloidogenic ␤-and ␥-secretase activities. Knowledge of the specific sequences of ␤APP, furin, and potentially other species of mRNA, and their interaction with cellular transport vehicles (i.e. microtubules, microtubule-associated proteins and/or neurofilament NF160), may be of great importance in studying mRNA movement from the cell bodies to SPs. Finally, particular interest is paid here to the biosynthesis of NF160 and its targeting to dendritic compartments as a phenomenon potentially related to the transformation of healthy dendrites into dystrophic dendrites.
